| Schedule of Basic and Diluted Earnings Per Share |
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (in thousands, except per share data) |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
| |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Numerator |
|
|
|
|
|
|
|
|
| Net increase (decrease) in net assets resulting from operations |
|
$ |
27,967 |
|
|
$ |
53,202 |
|
|
$ |
217,306 |
|
|
$ |
39,548 |
|
| Less: Total distributions declared |
|
(72,534) |
|
|
(63,950) |
|
|
(204,687) |
|
|
(181,825) |
|
| Total Earnings (loss), net of total distributions |
|
(44,567) |
|
|
(10,748) |
|
|
12,619 |
|
|
(142,277) |
|
| |
|
|
|
|
|
|
|
|
| Earnings (loss), net of distributions attributable to common shares |
|
(44,567) |
|
|
(10,748) |
|
|
12,486 |
|
|
(142,277) |
|
| Add: Distributions declared attributable to common shares |
|
71,860 |
|
|
63,421 |
|
|
202,556 |
|
|
180,114 |
|
| Numerator for basic and diluted change in net assets per common share |
|
$ |
27,293 |
|
|
$ |
52,673 |
|
|
$ |
215,042 |
|
|
$ |
37,837 |
|
| |
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
| Basic weighted average common shares outstanding |
|
146,899 |
|
127,484 |
|
141,223 |
|
123,379 |
| Common shares issuable |
|
211 |
|
1,850 |
|
903 |
|
1,388 |
| Weighted average common shares outstanding assuming dilution |
|
147,110 |
|
129,334 |
|
142,126 |
|
124,767 |
| |
|
|
|
|
|
|
|
|
| Change in net assets per common share: |
|
|
|
|
|
|
|
|
| Basic |
|
$ |
0.19 |
|
|
$ |
0.41 |
|
|
$ |
1.52 |
|
|
$ |
0.31 |
|
| Diluted |
|
$ |
0.19 |
|
|
$ |
0.41 |
|
|
$ |
1.51 |
|
|
$ |
0.30 |
|
|
| Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock |
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and nine months ended September 30, 2023, and 2022, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
| Anti-dilutive Securities |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Unvested common stock options |
|
347 |
|
865 |
|
1,782 |
|
1,725 |
| Restricted stock units |
|
— |
|
— |
|
5,810 |
|
— |
| Unvested restricted stock awards |
|
395 |
|
3,982 |
|
40,034 |
|
1,611 |
|
|
|
|
|
|
|
|
|
|